PRIMARY PREVENTION OF DEMENTIA
https://doi.org/10.51922/1818-426X.2024.1.139
Abstract
Every year there is an increase of almost 10 million cases of dementia worldwide. This disease is the seventh leading cause of death in the world and is one of the leading causes of disability in older people. Minimizing the pathological (social and economic) impact of dementia on society is based on improving the primary prevention model. Currently, there is an increase in evidence-based data on the harmful effects of potentially modifiable factors that can induce neurodegenerative diseases. The article contains information about hyperepithelial permeability syndrome, which leads to increased circulation of lipopolysaccharides; it is concluded that “dysbiosis” contributes to the development of neurodegenerative and neuroinflammatory changes in the central nervous system; the importance of the nutritional factor contributing to the development of the syndrome of increased epithelial permeability and “dysbiosis” is shown. The importance of moderate physical activity and neurocognitive training in the prevention is demonstrated. It is concluded that the primary focus of prevention methods is to eliminate the influence of exogenous factors (reducing/eliminating the impact of pathogenic herbicides and pesticides, stressinduced conditions), modifying nutritional factors (rational and balanced nutrition), but also stimulating the physical and intellectual activity of patients.
About the Authors
E. V. VistRussian Federation
A. V. Boika
Russian Federation
M. M. Sialitski
Russian Federation
References
1. Joanna, K. Winston et al. Glyphosate ifilt rates the brain and increases pro-inflammatory cytokine TNFα: implications for neurodegenerative disorders // Journal of Neuroinflammation. – 2022. – Vol. 19. – P. 193. – DOI: 10/1186/s12974-022-02544-5.
2. Nizhegorodova, D. B., Levkovskaya A. N. Zafranskaya M. M. Immunologicheskiye mekhanizmy neyrovospaleniya i neyrodegeneratsii // Immunopatologiya, allergologiya, infektologiya. – 2018. – № 4. – P. 27–42. – DOI: 10.14427/jipai.2018.4.27.
3. Simanenkov, V. I., Mayev I. V. et al. Sindrom povyshennoy epitelial’noy pronitsayemosti v klini cheskoy praktike. Mul’tidistsiplinarnyy natsional’nyy konsensus / Natsional’naya meditsinskaya Assotsiatsiya po izucheniyu Sochetannykh Zabolevaniy (NASZ); Professional’nyy fond sodeystviya razvitiya meditsiny «PROFMEDFORUM». – M., 2021. – 158 s.
4. Dr. Cristian, Follmer. Gut Microbiome imbalance and Neuroinflammation: Impact of COVID-19 on Parkinson’s Disease. Published online 21 August 2020 I n Wiley Online Library. – doi: 10.1002/mds.28231.
5. Ul’yanova, O. V. Glyuten i tseliakiya kak faktory riska razvitiya neyrodegenerativnykh zabolevaniy. Etiologiya, patogenez, klinika i osnovnyye puti profilaktiki. «Molodoy uchenyy», sentyabr’. – 2016. – № 18(122).
6. Bikbavova, G. R., Lopata S. I., Kidalov M. B., Akhmedov V. A. Potentsial’naya rol’ kishechnoy mikrobioty v formirovanii bolezni Al’tsgeymera // RMZH. – 2021. – № 6. – P. 93–95.
7. Sukhanov, A. V. Polinenasyshchennyye zhirnyye kisloty v lechenii i profilaktike kognitivnykh rasstroystv pozdnego vozrasta: sovremennoye sostoyaniye i perspektivy // Nauchno-prakticheskiy zhurnal Ateroskleroz. – 2021. – T. 8, № 1.
8. Borisov, M. Yu. Farmakognosticheskoye issledovaniye kornevishch kurkumy dlinnoy (Curcuma Longa L.): Dissertatsiya na soiskaniye uchenoy stepeni kandidata farmatsevticheskikh nauk. – Samara, 2017. – 166 s.
9. Adrendash, G. W., Cao C. Caffeine and coffe as the therapeutics against Alzheimer’s disease // J-Alzheimers-Dis. – 2010. – Suppl. 1. – S. 117–126. – DOI: 10.3233/JAD-2010-091249.
10. Latypova, Y. A. R., Landar’ L. N. Vozmozhnosti primeneniya kofeina dlya profilaktiki razvitiya bolezni Al’tsgeymera // Innovatsii v meditsine i farmatsii. BGMU. – 2018.
11. Levchenkova, O. S., Novikov V. Ye. Vozmozh nosti farmakologiyeskogo prekonditsionirovaniya // Vestnik RAMN. – 2016. – Vol. 71(1). – P. 16–24. – DOI: 10.15690/vramn626.
12. Yuusuke, Saitsu, Akemi Nishide, Kenji Kikushima, Kuniyoshi Shimizu, Koichiro Ohnuki. Improvement of cognitive functions by oral intake of Hericiumerinaceus // Biomedical Research. – 2019. – Vol. 40(4). – P. 125–131. – DOI: 10.2220/biomedres.40.125.
13. Gafarov, V. V., i soavt. Stress na rabochem meste i kognitivnyye funktsii (populyatsionnoye issledovaniye naseleniya v vozraste 25–44 let) // Nevrologiya, neyropsikhiatriya, psikhosomatika. – 2021. – № 13(4). – P. 30–36. – DOI: 10.14412/2074-2711-2021-4-30-36.
14. Boyko, A. V. «Avtovolnovaya poluten’» – terapevticheskaya mishen’ v nevrologii i meditsine // Voyennaya meditsina. – 2023. – № 3. – DOI: 10.51922/2074-5044.2023.3.53.
15. Gorshunova, N. i soavt. Profilaktika kognitivnykh narusheniy v deyatel’nosti vracha obshchey praktiki // Vrach. – 2018. – Vol. 29(6). – P. 45–47. – DOI: 10.29296/25877305-2018-06-09.
16. Pushkarev, R. I. i soavtr. Profilaktika dementsiy u lits pozhilogo vozrasta s pomoshch’yu kognitivnoy stimulyatsii. V Mezhdunarodnaya (75 Vserossiyskaya) nauchno-prakticheskaya konferentsiya “Aktual’nyye voprosy sovremennoy me ditsinskoy nauki i zdravookhraneniya”.
Review
For citations:
Vist E.V., Boika A.V., Sialitski M.M. PRIMARY PREVENTION OF DEMENTIA. Medical Journal. 2024;(1):139-148. (In Russ.) https://doi.org/10.51922/1818-426X.2024.1.139